XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.310
+0.040 (3.15%)
Apr 22, 2025, 1:03 PM EDT - Market open

XTL Biopharmaceuticals Statistics

Total Valuation

XTLB has a market cap or net worth of $10.97 million. The enterprise value is $9.24 million.

Market Cap 10.97M
Enterprise Value 9.24M

Important Dates

The next estimated earnings date is Monday, May 19, 2025, before market open.

Earnings Date May 19, 2025
Ex-Dividend Date n/a

Share Statistics

XTLB has 881.39 million shares outstanding. The number of shares has increased by 7.97% in one year.

Current Share Class n/a
Shares Outstanding 881.39M
Shares Change (YoY) +7.97%
Shares Change (QoQ) +31.89%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 749.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 238.38
Forward PS n/a
PB Ratio 1.92
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 200.79
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.81

Current Ratio 0.81
Quick Ratio 0.75
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -42.16

Financial Efficiency

Return on equity (ROE) is -25.70% and return on invested capital (ROIC) is -23.73%.

Return on Equity (ROE) -25.70%
Return on Assets (ROA) -16.33%
Return on Invested Capital (ROIC) -23.73%
Return on Capital Employed (ROCE) -22.90%
Revenue Per Employee $6,571
Profits Per Employee -$150,857
Employee Count 7
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -46.31% in the last 52 weeks. The beta is 1.01, so XTLB's price volatility has been similar to the market average.

Beta (5Y) 1.01
52-Week Price Change -46.31%
50-Day Moving Average 1.30
200-Day Moving Average 1.96
Relative Strength Index (RSI) 57.64
Average Volume (20 Days) 4,411

Short Selling Information

The latest short interest is 54,672, so 0.73% of the outstanding shares have been sold short.

Short Interest 54,672
Short Previous Month 56,279
Short % of Shares Out 0.73%
Short % of Float n/a
Short Ratio (days to cover) 8.37

Income Statement

In the last 12 months, XTLB had revenue of $46,000 and -$1.06 million in losses. Loss per share was -$0.00.

Revenue 46,000
Gross Profit 46,000
Operating Income -1.56M
Pretax Income n/a
Net Income -1.06M
EBITDA n/a
EBIT -1.56M
Loss Per Share -$0.00
Full Income Statement

Balance Sheet

The company has $1.72 million in cash and n/a in debt, giving a net cash position of $1.72 million or $0.00 per share.

Cash & Cash Equivalents 1.72M
Total Debt n/a
Net Cash 1.72M
Net Cash Per Share $0.00
Equity (Book Value) 5.72M
Book Value Per Share 0.01
Working Capital -480,000
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -3,391.30%
Pretax Margin -2,295.65%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XTLB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.97%
Shareholder Yield n/a
Earnings Yield -9.63%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2:1.

Last Split Date Feb 10, 2017
Split Type Reverse
Split Ratio 0.2:1

Scores

XTLB has an Altman Z-Score of -22.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -22.47
Piotroski F-Score n/a